|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-10-29
|
|
pubmed:abstractText |
The aims of this study were to determine if patients with SSRI-related hyponatraemia were (1) genetically poor metabolizers of CYP2D6, and/or (2) had excessive plasma concentrations of the SSRI antidepressant.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0885-6222
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
187-90
|
|
pubmed:dateRevised |
2008-3-6
|
|
pubmed:meshHeading |
pubmed-meshheading:12404686-Aged,
pubmed-meshheading:12404686-Aged, 80 and over,
pubmed-meshheading:12404686-Cytochrome P-450 CYP2D6,
pubmed-meshheading:12404686-Depressive Disorder,
pubmed-meshheading:12404686-Female,
pubmed-meshheading:12404686-Fluoxetine,
pubmed-meshheading:12404686-Genotype,
pubmed-meshheading:12404686-Humans,
pubmed-meshheading:12404686-Hyponatremia,
pubmed-meshheading:12404686-Male,
pubmed-meshheading:12404686-Middle Aged,
pubmed-meshheading:12404686-Paroxetine,
pubmed-meshheading:12404686-Risk Factors,
pubmed-meshheading:12404686-Serotonin Uptake Inhibitors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.
|
|
pubmed:affiliation |
Department of Clinical Pharmacology, Christchurch Hospital, Christchurch School of Medicine, Christchurch, New Zealand.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
